A detailed history of Numerai Gp LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Numerai Gp LLC holds 94,616 shares of TXG stock, worth $1.33 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
94,616
Previous 46,559 103.22%
Holding current value
$1.33 Million
Previous $906 Million 135.92%
% of portfolio
0.57%
Previous 0.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.71 - $23.49 $754,975 - $1.13 Million
48,057 Added 103.22%
94,616 $2.14 Billion
Q2 2024

Aug 14, 2024

BUY
$19.45 - $37.37 $905,572 - $1.74 Million
46,559 New
46,559 $906 Million
Q3 2023

Nov 13, 2023

SELL
$40.86 - $62.98 $2.18 Million - $3.36 Million
-53,428 Reduced 51.01%
51,303 $2.12 Billion
Q2 2023

Aug 11, 2023

BUY
$50.96 - $58.72 $5.34 Million - $6.15 Million
104,731 New
104,731 $5.85 Billion

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.33B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Numerai Gp LLC Portfolio

Follow Numerai Gp LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Numerai Gp LLC, based on Form 13F filings with the SEC.

News

Stay updated on Numerai Gp LLC with notifications on news.